Literature DB >> 35382250

Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers.

Francesca Crisafulli1, Maria-Grazia Lazzaroni1, Stefania Zingarelli1, Mara Rossi2, Angela Tincani1, Franco Franceschini1, Paolo Airò1.   

Abstract

Entities:  

Year:  2020        PMID： 35382250      PMCID： PMC8922635          DOI： 10.1177/2397198320952299

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN： 2397-1983


× No keyword cloud information.
  5 in total

1.  Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.

Authors:  Francesca Ingegnoli; Tommaso Schioppo; Yannick Allanore; Roberto Caporali; Michele Colaci; Oliver Distler; Daniel E Furst; Nicolas Hunzelmann; Florenzo Iannone; Dinesh Khanna; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2018-04-04       Impact factor: 5.532

2.  Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.

Authors:  Marco Matucci-Cerinic; Cosimo Bruni; Yannick Allanore; Massimo Clementi; Lorenzo Dagna; Nemanja S Damjanov; Amato de Paulis; Christopher P Denton; Oliver Distler; David Fox; Daniel E Furst; Dinesh Khanna; Thomas Krieg; Masataka Kuwana; Eun Bong Lee; Mengtao Li; Shiv Pillai; Yukai Wang; Xiaofeng Zeng; Gloria Taliani
Journal:  Ann Rheum Dis       Date:  2020-04-29       Impact factor: 19.103

3.  Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.

Authors:  Cosimo Bruni; Tanaka Ngcozana; Francesca Braschi; Tiziana Pucci; Guya Piemonte; Laura Benelli; Melissa Poli; Yossra A Suliman; Serena Guiducci; Silvia Bellando-Randone; Silvia Balduzzi; Jonathan Grotts; Christopher P Denton; Laura Rasero; CarloMaurizio Montecucco; Daniel E Furst; Marco Matucci-Cerinic
Journal:  J Rheumatol       Date:  2018-11-15       Impact factor: 4.666

4.  Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.

Authors:  Jérôme Avouac; Paolo Airó; Nicolas Carlier; Marco Matucci-Cerinic; Yannick Allanore
Journal:  Ann Rheum Dis       Date:  2020-06-05       Impact factor: 19.103

5.  The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress.

Authors:  Martina Orlandi; Gemma Lepri; Cosimo Bruni; Yukai Wang; Alessandro Bartoloni; Lorenzo Zammarchi; Laura Cometi; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Clin Rheumatol       Date:  2020-06-08       Impact factor: 2.980
  5 in total
  1 in total

1.  Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.

Authors:  Enrico De Lorenzis; Gerlando Natalello; Lucrezia Verardi; Pier Giacomo Cerasuolo; Laura Gigante; Maria Antonietta D'Agostino; Silvia Laura Bosello
Journal:  Microvasc Res       Date:  2022-07-11       Impact factor: 3.750
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.